Redeye retains its positive view on Sdiptech following two typical acquisitions, RDM and ELM.
Unikt fastighetsbolag... Arlandastad Group har förvärvat stora mängder råmark kring Arlanda och Stoc...
Redeye comments on the news that Avanza has decided to cancel the process regarding a potential part...
Mangold uppdaterar cybersäkerhetbolaget Cyber Security 1 ”CYBER1” efter kvartalsrapport.
Redeye initiates coverage of Beyond Frames, a market-leading VR game developer and publisher compris...
Value change potential from retail to CSP conversion Unsustainable yield spread prompts value declin...
Operational wheels spinning well, project costs up Higher interest rates behind estimate cuts 5y ave...
Higher interest rate expectations lower CEPS …but positive operational signs are encouraging EPRA NR...
Redeye has updated its view on W5 Solutions after solid Q1 results.
Redeye endorses aXichem signing a supply and research agreement worth around USD 5m with the Canadia...
Redeye comments on M.O.B.A’s partnership agreement with the fantasy game platform, E-GO APP.
Utvecklingsbolag med låg risk Iconovo hjälper generiska bolag samt andra läkemedelsbolag att utveckl...
Redeye comments on the recent news in the company and adjust for the recent capital injections in th...
Yesterday Inzile announced an order of 900 vehicles from Emos, the joint venture with Pinero Group t...
Biovica can point to significant progress lately. The FDA submission was cleared well before schedul...
Redeye views the deal with Exelixis, which provides BioInvent with a USD 25m upfront fee, as a usefu...
Redeye reviews its Fair Value Range for Sedana Medical and reconsiders some key assumptions.
Redeye comments on the news of Daniel Öhman being appointed as the new CEO of Carasent, following De...
Aspo’s guidance upgrade arrived sooner than we expected.
Rovio's performance has exceeded our expectations for three consecutive quarters, and the recent CMD...
